Navigation Links
Tumor-inhibiting protein could be effective in treating leukemia
Date:7/14/2008

Angiocidin, a tumor-inhibiting novel protein discovered by Temple University researchers, may also have a role as a new therapeutic application in treating leukemia, according to a study by the researchers.

The study, "The Novel Angiogenic Inhibitor, Angiocidin, Induces Differentiation of Monocytes to Macropahges," will be published in the July 15 issue of the journal Cancer Research (http://cancerres.aacrjournals.org/future/68.14.shtml). The research was done by Temple biology doctoral student Anita Gaurnier-Hausser under the direction of George Tuszynski, a professor of neuroscience in Temple's School of Medicine and a professor of biology in Temple's College of Science and Technology.

"Angiocidin is a protein that has a lot of anti-cancer activity and inhibits angiogenesis, a physiological process involving the growth of new blood vessels from pre-existing vessels, which is a fundamental step in the transition of tumors from a dormant state to a malignant state," said Tuszynski, who discovered the protein.

Tuszynski said that over the years, the researchers had looked at the protein's effect on solid tumors like breast cancer, prostate cancer and colon cancer.

"All of these cancers are inhibited by Angiocidin by virtue of the fact that this protein inhibits vascularization or the formation of new vessels," he said. "We decided we wanted to look to see if Angiocidin had any effect on hematologic malignancy, and we chose leukemia."

Tuszynski said leukemia cells arise from monocytes, a specific white blood cell that is a part of the human body's immune system that protects against bloodborne pathogens and moves quickly to sites of infection. As monocytes enter tissue, they undergo a series of changes to become macrophages.

When the researchers treated the leukemia cells, "our molecule was able to induce a differentiation of these mono
'/>"/>

Contact: Preston M. Moretz
pmoretz@temple.edu
215-204-4380
Temple University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Wasps and bumble bees heat up, fly faster with protein-rich food
2. Protein marker for schizophrenia risk
3. Scientists reveal the key mechanisms for affinity between transient binding proteins
4. Small protein may have big role in making more bone and less fat
5. A mammalian clock protein responds directly to light
6. Scientists find potential protein biomarkers for growth hormone
7. Rong Li Lab identifies new role of inflammatory protein in PKD and a possible treatment
8. Researchers reveal insights into hidden world of protein folding
9. Mechanism explains link between apolipoprotein E and Alzheimers disease
10. A protein sequence associated with Huntington’s disease may become life-saving vaccine component
11. Fruit fly helps identify protein critical to eggshell formation that may be pesticide target

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...l Center and the Chinese Academy of Sciences (CAS)... on Taste and Smell Research. Organized by Monell ... the first international meeting on taste and smel...cutive Officer, American Association for the Advan...ce magazine, will open the meeting with a plenary ...
(Date:11/4/2009)... United States Using Less Water Today , The U...years ago, despite a 30 percent population increas...o alternative cooling methods at power plants and ...e latest USGS water use report, nearly half of all...hermoelectric power plants. Irrigation accounts fo...
(Date:11/4/2009)...ceived more than $10 million in research grants fr...imulus program, bringing thetotal amount of stimul...on. Thirty-three projects achieved stimulus fundi.... , "The university has thoughtfully undertaken ...y excellence to federal agency priorities. Throug...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3HCA Appoints Dr Richard Tayrien Chief Health Information Officer 56033 1HCA Appoints Dr Richard Tayrien Chief Health Information Officer 56033 2Associated Press Cites Mexico as Example of H1N1 Success 56031 1Cinergy Health Names Dr Margaret Lewin Chief Medical Director 56029 1Cinergy Health Names Dr Margaret Lewin Chief Medical Director 56029 2
...e that high doses of an experimental H5N1 avian in...lthy adults. , Approximately half of those volunt... the highest dosage of the vaccine tested in the t...dies that current tests predict would neutralize t...fectious Diseases (NIAID), part of the National In...
... by how fast the thinking part of their brains thi...e National Institutes of Health,s (NIH) National I... , Magnetic resonance imaging (MRI) scans showed t...s more rapidly during childhood, reaching its peak...onger developmental window for high-level thinking...
...e first time, the failure of previous attempts to ...nd it suggests a very simple solution ?injecting t...ions on the body. , A mosquito-born disease, Dengu...ickens 100 million more. Known as "bone-break dise... and was "the most important mosquito-borne viral ...
Other Biology News:H5N1 avian flu virus vaccine induces immune responses in healthy adults 2H5N1 avian flu virus vaccine induces immune responses in healthy adults 3Cortex matures faster in youth with highest IQ 2Simple idea to dramatically improve dengue vaccinations 2Simple idea to dramatically improve dengue vaccinations 3
(Date:11/5/2009)...YVALE, Calif., Nov. 5 Ce...ecutives will be speaking at the following investo...e via webcast. , , Credit Suisse H... Thursday, 12 November, 2009 at 10 a.m. Mountain T...gram, London, England, Tuesday, 1 ...
(Date:11/5/2009)...PLYMOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asia-Fir... ) ("BMP Sunstone" or the "Company") today announc... 2009 financial results on,Monday, November 9, 200... will hold a conference call at 5:00 pm ET on Nove.... Listeners may access the call by,dialing 1-888-...
(Date:11/4/2009)... The Human Anthrax Vaccine Program ...pleted the feature film "A Call to Arms:2009 ...ary "Fatal Immunity: The Human Anthrax Vaccin... and present danger of top secret government scien...ith no accountability to its victims. It is avail...
(Date:11/4/2009)...CARLOS, Calif., Nov. 4 N... its financial results for the third quarter ended...er ended September 30, 2009 improved to $31.0 mill...of $37.0 million or $0.40 per share in the third q...improvements to its operating efficiencies as comp...
Breaking Biology Technology:Cepheid to Webcast Upcoming Financial Presentations 2BMP Sunstone to Report Third Quarter 2009 Financial Results 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10
...er 11 , - SCRIP Awards Recognises the Best and ...Industries Worldwide, - Glenmark is the Only In...us Recognition, , The best and brightest of ...ebrated at a glittering ceremony in London at the ...ster Peter Sissons on December 10th. At this award...
... Several leading LASIK and refractive eye sur...directory were actively involved at the recently c...nnual meeting in Atlanta. Dr. Randy Epstein, Dr. ...man, Dr. Edward Manche, Dr. Jason Stahl, and Dr. B...pecialists educated their peers on the latest deve...
... McCulley/Cuppan announced today the launch o...professionals in the biopharmaceutical and life sc...ot; courses are one hour in duration and designed ...refine their technical writing skills. , ...ber 11, 2008 -- McCulley/Cuppan announced today th...
Other Biology Technology:SCRIP, the Leading Pharmaceutical Magazine in the World Crowns Glenmark as the "Best Pharma Company in the World - SME" and the "Best Company in Emerging Markets" at the SCRIP Awards 2008 in London 2Top LASIK and Refractive Experts in Trusted LASIK Surgeons Directory Present Research and Educate Their Peers at Annual AAO Meeting in Atlanta 2Top LASIK and Refractive Experts in Trusted LASIK Surgeons Directory Present Research and Educate Their Peers at Annual AAO Meeting in Atlanta 3Top LASIK and Refractive Experts in Trusted LASIK Surgeons Directory Present Research and Educate Their Peers at Annual AAO Meeting in Atlanta 4Top LASIK and Refractive Experts in Trusted LASIK Surgeons Directory Present Research and Educate Their Peers at Annual AAO Meeting in Atlanta 5Top LASIK and Refractive Experts in Trusted LASIK Surgeons Directory Present Research and Educate Their Peers at Annual AAO Meeting in Atlanta 6Top LASIK and Refractive Experts in Trusted LASIK Surgeons Directory Present Research and Educate Their Peers at Annual AAO Meeting in Atlanta 7Top LASIK and Refractive Experts in Trusted LASIK Surgeons Directory Present Research and Educate Their Peers at Annual AAO Meeting in Atlanta 8Top LASIK and Refractive Experts in Trusted LASIK Surgeons Directory Present Research and Educate Their Peers at Annual AAO Meeting in Atlanta 9McCulley/Cuppan Announced Today The Launch Of A New Series Of Web-Based Training Programs For Professionals In The Biopharmaceutical And Life Science Industries 2McCulley/Cuppan Announced Today The Launch Of A New Series Of Web-Based Training Programs For Professionals In The Biopharmaceutical And Life Science Industries 3
Mouse Anti-Human Vasopressin Monoclonal Antibody, Unconjugated, Clone VAS 2-10-8 from Meridian Life Science, Inc.
Mouse Anti-PCTAIRE 2 Monoclonal Antibody, Unconjugated, Clone 0.N.509 from Abcam
MMP-2/MMP-9 Inhibitor IV [SB-3CT] from CHEMICON
...oprietary high-performance desalting resin, exclus...nd protein-recovery characteristics compared to ot...ing as low as 25 g/ml of protein can be processed,...retention of salts and other small molecules ( Ex...
Biology Products: